4//SEC Filing
CORTEX PHARMACEUTICALS INC/DE/ 4
Accession 0001363763-15-000012
CIK 0000849636operating
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 5:23 PM ET
Size
8.3 KB
Accession
0001363763-15-000012
Insider Transaction Report
Form 4
WEINGARTEN ROBERT N
DirectorVice President and CFO
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2015-08-18+10,000,000→ 10,000,000 totalExercise: $0.02Exp: 2022-08-18→ Common Stock (10,000,000 underlying)
Holdings
- 5,000,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $0.05Exp: 2019-07-17→ Common Stock (5,000,000 underlying) - 15,000,000
Common Stock Options (to purchase shares of Common Stock)
Exercise: $0.03Exp: 2022-06-30→ Common Stock (15,000,000 underlying)
Footnotes (3)
- [F1]These Common Stock Options vest in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016.
- [F2]These Common Stock Options vest in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015.
- [F3]These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable.
Documents
Issuer
CORTEX PHARMACEUTICALS INC/DE/
CIK 0000849636
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000849636
Filing Metadata
- Form type
- 4
- Filed
- Aug 19, 8:00 PM ET
- Accepted
- Aug 20, 5:23 PM ET
- Size
- 8.3 KB